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Background 
Pregnant women who are obese are 
more likely to have gestational diabetes, 
gestational hypertension, pre-eclampsia, 
macrosomia, operative vaginal delivery, 
and cesarean delivery. Obesity also has 
adverse implications for the neonate. 
Congenital anomalies are more 
common in children born to obese 
women. These include neural tube 
defects, gastroschisis, cardiovascular 
anomalies, and others. Although the 
connection between maternal obesity 
and chronic health conditions has been 
described, the mechanism by which this 
occurs is less well understood. Changes 
to the epigenetic structure of offspring 
DNA have been proposed as one such 
mechanism.  
 
 
Methods 
Cord blood specimens were collected by 
the Maternal Fetal Tissue Bank (IRB# 
200910784). (N=53 non-obese maternal 
subjects, N=55 obese subjects). Cord 
blood DNA was extracted from 
mononuclear cells using the Genomic 
DNA Mini-Kit from IBI Scientific. The 
total amount of methylated DNA in each 
sample of 200mg total DNA was 
calculated using a commercial 
methylated DNA quantification kit, the 
Imprint Methylated DNA Quantification 
Kit (Sigma-Aldrich Scientific). Samples 
were assayed in duplicate. For both 
obese and non-obese cohorts, total 
methylated DNA in a 200 ng sample 
was calculated as our primary outcome. 
For secondary outcomes, pre-
eclampsia, prematurity, gestational 
diabetes, IUGR, PVL, NEC, respiratory 
distress syndrome (RDS), 5-minute 
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Apgars <7, NICU admission, 
hypoglycemia, and hyperbilirubinemia 
were analyzed against total fetal DNA 
methylation to determine whether there 
was a correlation using bivariate and 
multivariate regression analysis. 
Results 
We did not find a statistically significant 
relationship between maternal BMI and 
cord blood total DNA methylation. For 
non-obese gravidas, the average total 
fetal DNA methylation was 7.6%. For 
obese gravidas, the average total fetal 
DNA methylation was 6.4%. (p = 0.249). 
In terms of our secondary outcomes, 
respiratory distress syndrome (RDS) 
and NICU admission were both 
significantly associated with decreased 
global DNA methylation. The secondary 
outcomes of prematurity, pre-eclampsia, 
gestational diabetes, IUGR, 5-minute 
Apgar <7, NICU stay >24 hours, 
hypoglycemia requiring IV dextrose, and 
hyperbilirubinemia requiring 
phototherapy did not show a statistically 
significant correlation to global fetal 
DNA methylation. 
Conclusions 
Although we did not find a relationship 
between maternal BMI and fetal DNA 
methylation, this does not rule out the 
possibility that such a relationship may 
exist. Our study may have been 
underpowered to detect such a 
difference. Our study did show a 
correlation between neonatal RDS and 
NICU admission and global DNA 
hypomethylation. These are promising 
avenues of future research.   
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